Palo Alto Investors LP Long-Term Concentrated

Location: Palo Alto, CA

CIK: 0001306923 · Show all filings

Period: Q2 2026 (← Previous)

Filing Date: Aug 19, 2026

Total Value: $724M (100.0% shares, 0.0% debt)

Holdings (52)

Exited Positions (2)

Decreased Positions (8)

Unchanged Positions (36)

INSM INSMED INC 6.1%
Value $44.14M Shares 413,980 Share Price $106.62 Est. Cost/Share $17.79 Unrealized @ Report Date —
PTCT PTC THERAPEUTICS INC 10.4%
Value $74.95M Shares 918,846 Share Price $81.57 Est. Cost/Share $46.78 Unrealized @ Report Date —
ACAD ACADIA PHARMACEUTICALS INC 10.0%
Value $72.46M Shares 2,864,096 Share Price $25.30 Est. Cost/Share $26.72 Unrealized @ Report Date —
RARE ULTRAGENYX PHARMACEUTICAL IN 2.8%
Value $19.92M Shares 596,495 Share Price $33.39 Est. Cost/Share $29.43 Unrealized @ Report Date —
DYN DYNE THERAPEUTICS INC 5.1%
Value $36.59M Shares 1,647,521 Share Price $22.21 Est. Cost/Share $13.45 Unrealized @ Report Date —
CDNA CAREDX INC 2.1%
Value $15.16M Shares 531,870 Share Price $28.50 Est. Cost/Share $15.56 Unrealized @ Report Date —
NVCR NOVOCURE LTD 2.7%
Value $19.4M Shares 1,280,439 Share Price $15.15 Est. Cost/Share $34.92 Unrealized @ Report Date —
BCAX BICARA THERAPEUTICS INC 2.3%
Value $16.34M Shares 550,408 Share Price $29.69 Est. Cost/Share $16.72 Unrealized @ Report Date —
BIIB BIOGEN INC 4.2%
Value $30.31M Shares 140,279 Share Price $216.06 Est. Cost/Share $256.18 Unrealized @ Report Date —
ALKS ALKERMES PLC 1.8%
Value $12.71M Shares 242,560 Share Price $52.39 Est. Cost/Share $24.20 Unrealized @ Report Date —
UTHR UNITED THERAPEUTICS CORP 4.7%
Value $33.91M Shares 62,587 Share Price $541.83 Est. Cost/Share $118.03 Unrealized @ Report Date —
TSHA TAYSHA GENE THERAPIES INC 1.3%
Value $9.475M Shares 1,391,382 Share Price $6.81 Est. Cost/Share $2.31 Unrealized @ Report Date —
ACRS ACLARIS THERAPEUTICS INC 1.2%
Value $8.535M Shares 1,613,430 Share Price $5.29 Est. Cost/Share $1.50 Unrealized @ Report Date —
CAPR CAPRICOR THERAPEUTICS INC 0.8%
Value $5.533M Shares 229,763 Share Price $24.08 Est. Cost/Share $13.24 Unrealized @ Report Date —
SNDX SYNDAX PHARMACEUTICALS INC 2.6%
Value $18.91M Shares 864,986 Share Price $21.86 Est. Cost/Share $16.22 Unrealized @ Report Date —
CMPS COMPASS PATHWAYS PLC ADR 0.2%
Value $1.636M Shares 115,616 Share Price $14.15 Est. Cost/Share $6.90 Unrealized @ Report Date —
HUM HUMANA INC 0.2%
Value $1.583M Shares 3,985 Share Price $397.22 Est. Cost/Share $369.63 Unrealized @ Report Date —
AGIO AGIOS PHARMACEUTICALS INC 1.1%
Value $7.927M Shares 213,601 Share Price $37.11 Est. Cost/Share $33.17 Unrealized @ Report Date —
NBIX NEUROCRINE BIOSCIENCES INC 0.4%
Value $3.053M Shares 18,117 Share Price $168.54 Est. Cost/Share $129.01 Unrealized @ Report Date —
CYTK CYTOKINETICS INC 0.4%
Value $2.743M Shares 32,195 Share Price $85.19 Est. Cost/Share $64.44 Unrealized @ Report Date —
ANNX ANNEXON INC 2.3%
Value $16.83M Shares 2,948,090 Share Price $5.71 Est. Cost/Share $4.19 Unrealized @ Report Date —
URGN UROGEN PHARMA LTD 0.1%
Value $902K Shares 24,500 Share Price $36.80 Est. Cost/Share $27.01 Unrealized @ Report Date —
BMRN BIOMARIN PHARMACEUTICAL INC 5.4%
Value $39.07M Shares 682,777 Share Price $57.22 Est. Cost/Share $83.16 Unrealized @ Report Date —
EW EDWARDS LIFESCIENCES CORP 0.4%
Value $3.043M Shares 33,640 Share Price $90.46 Est. Cost/Share $72.66 Unrealized @ Report Date —
EHTH EHEALTH INC 0.3%
Value $2.209M Shares 1,482,797 Share Price $1.49 Est. Cost/Share $38.13 Unrealized @ Report Date —
CRSP CRISPR THERAPEUTICS AG 0.3%
Value $2.16M Shares 39,605 Share Price $54.54 Est. Cost/Share $38.70 Unrealized @ Report Date —
XERS XERIS BIOPHARMA HOLDINGS INC 0.1%
Value $827K Shares 104,410 Share Price $7.92 Est. Cost/Share $7.21 Unrealized @ Report Date —
ABEO ABEONA THERAPEUTICS INC 0.1%
Value $673K Shares 108,865 Share Price $6.18 Est. Cost/Share $6.04 Unrealized @ Report Date —
XENE XENON PHARMACEUTICALS INC 0.4%
Value $3.099M Shares 51,345 Share Price $60.36 Est. Cost/Share $42.00 Unrealized @ Report Date —
BNTX BIONTECH SE-ADR 0.3%
Value $1.825M Shares 19,614 Share Price $93.05 Est. Cost/Share $118.77 Unrealized @ Report Date —
BCYC BICYCLE THERAPEUTICS PLC-ADR 0.1%
Value $856K Shares 201,890 Share Price $4.24 Est. Cost/Share $16.07 Unrealized @ Report Date —
ALDX ALDEYRA THERAPEUTICS INC 0.0%
Value $332K Shares 155,709 Share Price $2.13 Est. Cost/Share $5.95 Unrealized @ Report Date —
INSP INSPIRE MEDICAL SYSTEMS INC 0.1%
Value $391K Shares 8,772 Share Price $44.61 Est. Cost/Share $95.68 Unrealized @ Report Date —
PRQR PROQR THERAPEUTICS NV 0.0%
Value $351K Shares 188,807 Share Price $1.86 Est. Cost/Share $2.18 Unrealized @ Report Date —
MDGL MADRIGAL PHARMACEUTICALS INC 0.1%
Value $960K Shares 1,787 Share Price $536.95 Est. Cost/Share $492.48 Unrealized @ Report Date —
STOK STOKE THERAPEUTICS INC 0.4%
Value $2.769M Shares 84,631 Share Price $32.72 Est. Cost/Share $9.90 Unrealized @ Report Date —